Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 55-62 , 15 July 2003

Health-related quality of life and depression in an Italian sample of multiple sclerosis patients

  • Francesco Patti

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39-95-256620, mobile: +39-3386270548; fax: +39-95-330943, +39-95-7641423.
    • Dipartimento Neuroscienze, Sezione Sclerosi Multipla e Malattie Demielinizzanti, Azienda Policlinico Via Santa Sofia 78, 95123 Catania, Italy
    • ,
  • Manuela Cacopardo

      Affiliations

    • Dipartimento Neuroscienze, Sezione Sclerosi Multipla e Malattie Demielinizzanti, Azienda Policlinico Via Santa Sofia 78, 95123 Catania, Italy
    • ,
  • Filippo Palermo

      Affiliations

    • Istituto di Infettivologia, Università di Catania, Catania, Italy
    • ,
  • Maria Rita Ciancio

      Affiliations

    • Dipartimento Neuroscienze, Sezione Sclerosi Multipla e Malattie Demielinizzanti, Azienda Policlinico Via Santa Sofia 78, 95123 Catania, Italy
    • ,
  • Rossella Lopes

      Affiliations

    • Dipartimento Neuroscienze, Sezione Sclerosi Multipla e Malattie Demielinizzanti, Azienda Policlinico Via Santa Sofia 78, 95123 Catania, Italy
    • ,
  • Domenico Restivo

      Affiliations

    • Dipartimento Neurologia Azienda, Ospedaliera Garibaldi, Italy
    • ,
  • Arturo Reggio

      Affiliations

    • Dipartimento Neuroscienze, Sezione Sclerosi Multipla e Malattie Demielinizzanti, Azienda Policlinico Via Santa Sofia 78, 95123 Catania, Italy

Received 15 November 2002 ,Revised 5 February 2003 ,Accepted 5 February 2003.

References 

  1. Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual. Life Res. 1993 Dec;2(6):367–368
  2. Hastings D. Adjustment, coping resources, and care of the patient with multiple sclerosis. In:  Miller JF editors. Coping with Chronic Illness. Overcoming Powerlessness. 2nd ed.. Philadelphia: FA Davis; 1992;p. 222–254
  3. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  4. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult. Scler. Clin. Issues. 1995;1:37–47
  5. Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: II. Quality of life. Can. J. Neurol. Sci. 1998;25:31–38
  6. Vickrey BG, Hays RD, Harooni R, Myers LW, Elfison GW. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995;4:187–206
  7. Hobart JC. Measuring health outcomes in multiple sclerosis: why, which, and how?. In:  Thompson AJ,  Polman C,  Holfeld R editor. Multiple Sclerosis: Clinical Challenges and Controversies. London: Martin Dunitz; 1997;p. 211–225
  8. Rothwell PM, McDowel JD, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997;314:1580–1583
  9. Pfennings LEMA, Cohen L, Ader H, et al.  Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J. Neurol. 1999;246:587–591
  10. Nortvedt M, Riise T, Myhr KM, Nyland HI. Quality of life as a predictor for change in disability in MS. Neurology. 2000;55:51–54
  11. Solari A, Filippini G, Mendozzi L, et al.  Validation of Italian multiple sclerosis quality of life questionnaire. J. Neurol. Neurosurg. Psychiatry. 1999;67:158–162
  12. Amato MP, Ponziani G, Rossi F, et al.  Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult. Scler. 2001;7:340–344
  13. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston: Nimrod; 1993;
  14. Ware JE, Sherbourne CD. The MOS-36 item short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care. 1992;30:473–483
  15. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care. 1993;31:247–263
  16. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston (MA): The Health Institute; 1994;
  17. Nicoletti A, Lo Bartolo ML, Lo Fermo S, et al.  Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology. 2001;56:62–66
  18. Aronson NK, Acquadro C, Alonso J, et al.  International quality of life assessment (IQOLA) project. Qual. Life Res. 1992;1:349–351
  19. Apolone G, Cifani S, Liberati MC, et al.  Questionario sullo stato di salute SF-36. T raduzione e validazione della versione italiana: risultati del progetto IQOLA. Medic. 1997;5:86–94
  20. Apolone G, Mosconi P. The Italian SF-36 Health survey: translation, validation and norming from a clinical epidemiology perspective. J. Clin. Epidemiol. 1998;51:1025–1036
  21. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. Arch. Gen. Psychiatry. 1961;4:561–571
  22. Salkind MR. Beck depression inventory in general practice. J. R. Coll. Gen. Pract. 1969;18:267–271
  23. House A. Mood disorders after stroke: a review of the evidence. Int. J. Geriatr. Psychiatry. 1987;2:211–221
  24. Measso G, Cavarzeran F, Zappalà G, et al.  The mini-mental state examination: normative study of an Italian random sample. Dev. neuropsychol. 1993;9:77–85
  25. Newman D. The distribution of range in samples from a normal population expressed in terms of an independent estimate of standard deviation. Biometrika. 1939;31:20–30
  26. Keuls M. The uaae of “Studentized range” in connection with an analysis of variances. Euphytica. 1952;1:112–122
  27. Swanson JW. Multiple sclerosis: update in diagnosis and review of prognostic factors. Mayo Clin. Proc. 1989;64:577–586
  28. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Masurement of health-related quality of life in multiple sclerosis patients. Can. J. Neurol. Sci. 1996;23:99–103
  29. Verdier-Taillefer MH, Roullet E, Cesaro P, Alperovitch A. Validation of self-reported neurological disability in multiple sclerosis. Int. J. Epidemiol. 1994;23:148–154
  30. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology. 1997;48:74–80
  31. Sadovnik AD, Rernick RA, Allen J, et al.  Depression and multiple sclerosis. Neurology. 1996;46:628–632
  32. Joffe RT, Lippert GP, Gray TA. Depression and multiple sclerosis. Arch. Neurol. 1987;44:376–378
  33. Minden S, Orav J, Reich P. Depression in multiple sclerosis. Gen. Hosp. Psych. 1987;9:426–434
  34. Berwick DM. Performances of a 5-item mental health screening test. Medical Care. 1991;29:169–176
  35. Murphy N, Confavreux C, Haas J, et al.  Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. J. Neurol. Neurosurg. Psychiatry. 1998;65:460–466
  36. Patti F, Pozzilli C, Montanari E, Levi A, Menta L, Fiorilla T, et al.  The health related quality of life of patients with relapsing-remitting multiple sclerosis. An Italian longitudinal prospect multicenter study. J. Neurol. 2002;249(Suppl. 1):39
  37. Freeman JA, Hobart JC, Thompson AJ. Does adding MS-specific items to a generic measures (the SF-36) improve measurement?. Neurology. 2001;57:68–74
  38. Lintern TC, Beaumont JG, Kenealy PM, et al.  Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Qual. Life Res. 2001;10(4):371–378
  39. Weinstock-Guttman B, Jacobs LD. What is new in the treatment of multiple sclerosis?. Drugs. 2000;59:401–410

PII: S0022-510X(03)00040-6

doi: 10.1016/S0022-510X(03)00040-6

Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 55-62 , 15 July 2003

Article Tools

* Image Usage & Resolution